Evidence map›Paper›PMID 35251185›Full record

ArticleStem cells international2022

Cell Surface Proteins for Enrichment and

Sin-Ruow Tey, Madison Mueller, Megan Reilly, Colton Switalski, Samantha Robertson, Mariko Sakanaka-Yokoyama, Masatoshi Suzuki

Open access · goldAbstract read
In one paragraph

Article in Stem cells international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Genetic Deletion of the Purinergic ReceptorACS pharmacology & translational science · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Sin-Ruow TeyDepartment of Comparative Biosciences, University of Wisconsin-Madison, Wisconsin, USA.ORCID https://orcid.org/0000-0001-9742-0236
Madison MuellerDepartment of Comparative Biosciences, University of Wisconsin-Madison, Wisconsin, USA.ORCID https://orcid.org/0000-0001-6146-0500
Megan ReillyDepartment of Comparative Biosciences, University of Wisconsin-Madison, Wisconsin, USA.ORCID https://orcid.org/0000-0002-6586-2547
Colton SwitalskiDepartment of Comparative Biosciences, University of Wisconsin-Madison, Wisconsin, USA.
Samantha RobertsonDepartment of Comparative Biosciences, University of Wisconsin-Madison, Wisconsin, USA.ORCID https://orcid.org/0000-0002-4571-2728
Mariko Sakanaka-YokoyamaDepartment of Comparative Biosciences, University of Wisconsin-Madison, Wisconsin, USA.ORCID https://orcid.org/0000-0001-5517-2545
Masatoshi SuzukiDepartment of Comparative Biosciences, University of Wisconsin-Madison, Wisconsin, USA.ORCID https://orcid.org/0000-0003-3253-0711
University of Wisconsin–Madison · US

Funding

Stem cell-based tissue engineering for myotendinous junction modeling and repairR01AR077191 · NIAMS · UNIVERSITY OF WISCONSIN-MADISON · PI SUZUKI, MASATOSHI · 2020 to 2024
$1.7M
Muscle stem cells: New ALS growth factor therapy and disease modelR01NS091540 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI SUZUKI, MASATOSHI · 2015 to 2019
$1.7M
NIAMS NIH HHS R01 AR077191NINDS NIH HHS R01 NS091540
6 · The paper itself

Abstract

Human myogenic progenitors can be derived from pluripotent stem cells (PSCs) for use in modeling natural and pathological myogenesis, as well as treating muscle diseases. Transgene-free methods of deriving myogenic progenitors from different PSC lines often produce mixed populations that are heterogeneous in myogenic differentiation potential, yet detailed and accurate characterization of human PSC-derived myogenic progenitors remains elusive in the field. The isolation and purification of human PSC-derived myogenic progenitors is thus an important methodological consideration when we investigate the properties and behaviors of these cells in culture. We previously reported a transgene-free, serum-free floating sphere culture method for the derivation of myogenic progenitors from human PSCs. In this study, we first performed comprehensive cell surface protein profiling of the sphere culture cells through the screening of 255 antibodies. Next, we used magnetic activated cell sorting and enriched the cells according to the expression of specific surface markers. The ability of muscle differentiation in the resulting cells was characterized by immunofluorescent labeling and quantification of positively stained cells. Our results revealed that myotube-forming cells resided in the differentiated cultures of CD29

Identifiers

PMID35251185
PMCPMC8894063
OpenAlexW4214637155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.